StonvexLoading…
StonvexStonvexStonvexCore line items from LPSN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-10 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $49.94M | $56.96M | $243.74M | $184.45M | $124.30M |
Operating Income | Not available | $-1.75M | $-78.70M | $-37.96M | $-23.38M |
Net Income | Not available | $-8.83M | $-67.23M | $-21.13M | $-15.71M |
EPS (Diluted) | $-1.42 | $-0.73 | $-12.39 | $-7.16 | $-0.37 |
Total Assets | Not available | $457.58M | $454.67M | $511.45M | $604.21M |
Total Liabilities | Not available | $509.08M | $499.16M | $512.84M | $686.63M |
Cash & Equivalents | Not available | $101.50M | $95.00M | $106.66M | $161.96M |
Free Cash Flow OCF − CapEx | Not available | $6.90M | $-42.52M | $-30.57M | $-21.67M |
Shares Outstanding | Not available | 12.10M | 12.04M | 10.30M | 96.61M |